EAST LANSING, MI
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MICHIGAN BIOTECHNOLOGY INSTITUTE, founded in 1981, is a micro nonprofit in the Education sector that reported $3K in total revenue in fiscal year 2022. Revenue fell 94% from the prior year — a significant decline worth monitoring. Expenses of $95K exceeded revenue, resulting in a 3128% operating deficit.
BRIDGING THE GAP BETWEEN EARLY-STAGE INNOVATION AND COMMERCIAL APPLICATION PARTNERING TO DE-RISK, DEVELOP AND SCALE-UP DISCOVERIES INTO COMMERCIALLY-VIABLE TECHNOLOGY PACKAGES.
RESEARCH AND DEVELOPMENT - PRIVATE, NOT-FOR-PROFIT TECHNOLOGY DEVELOPMENT AND COMMERCIALIZATION CORPORATION ORGANIZED TO MEET AGRICULTURAL, INDUSTRIAL, AND ENVIRONMENTAL MARKET NEEDS BY DEVELOPING...
RESEARCH AND DEVELOPMENT - PRIVATE, NOT-FOR-PROFIT TECHNOLOGY DEVELOPMENT AND COMMERCIALIZATION CORPORATION ORGANIZED TO MEET AGRICULTURAL, INDUSTRIAL, AND ENVIRONMENTAL MARKET NEEDS BY DEVELOPING AND SCALING UP COMMERCIALLY PROMISING TECHNOLOGIES. MBI'S MISSION IS TO CREATE MEANINGFUL SOCIETAL BENEFITS BY COLLABORATING WITH UNIVERSITIES, GOVERNMENTS, FOUNDATIONS AND COMPANIES TO ACCELERATE THE COMMERCIALIZATION OF BIOBASED TECHNOLOGIES. MBI PROVIDES BUSINESS AND TECHNICAL EXPERTISE TO DEVELOP AND DERISK EARLY-STAGE BIOBASED TECHNOLOGIES, ULTIMATELY DEMONSTRATING TECHNO-ECONOMIC VIABILITY AT PILOT SCALE AND PREPARING THE TECHNOLOGIES FOR TRANSITION TO COMMERCIAL PARTNERS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $2,936 | $47,911 | -0.9% |
| Expenses | $94,778 | $99,126 | 0.0% |
| Net Income | $-91,842 | $-51,215 | +0.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DAVID WASHBURN | PRESIDENT & CHAIR | 1.00 |
Officer
Director
|
$0 | $58,630 | $448,827 |
| REBEKAH SKRZYNIARZ | DIR. OF FINANCE & TREASURER | 1.00 |
Officer
Director
|
$0 | $34,969 | $194,425 |
| ALLEN JULIAN | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $2,936 | $94,778 | $626,700 | $-91,842 |
| 2022 | $47,911 | $99,126 | $718,619 | $-51,215 |
| 2021 | $17,281 | $105,843 | $770,303 | $-88,562 |
| 2020 | $253,225 | $467,306 | $861,027 | $-214,081 |
| 2019 | $814,106 | $910,190 | $1,224,594 | $-96,084 |
| 2018 | $696,635 | $1,096,433 | $1,742,415 | $-399,798 |
Compare MICHIGAN BIOTECHNOLOGY INSTITUTE with other nonprofits in Michigan and across the country.